Cargando…
An open-label study of oral acetazolamide for the prevention of antipsychotic associated weight gain
BACKGROUND: Weight gain associated with atypical antipsychotic medications need to be well managed. We set out: 1. To test the effect of acetazolamide on weight gain associated with antipsychotics 2. To assess improvement in psychotic symptoms using the Brief Psychiatric Rating Scale score on patien...
Autores principales: | Priyamkari, Anupama, Kakunje, Anil, Nimgaonkar, Vishwajit L., Deshpande, Smita, Bhatia, Triptish, Wood, Joel, Kini, Ganesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236665/ https://www.ncbi.nlm.nih.gov/pubmed/37274570 http://dx.doi.org/10.4103/ipj.ipj_5_22 |
Ejemplares similares
-
Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia
por: Kakunje, Anil, et al.
Publicado: (2018) -
Assessment of Severity of Autism Using the Indian Scale for Assessment of Autism
por: Chakraborty, Satabdi, et al.
Publicado: (2015) -
Knowledge & attitudes of mental health professionals regarding psychiatric research
por: Mishra, N.N., et al.
Publicado: (2014) -
Attempts to replicate genetic associations with schizophrenia in a cohort from north India
por: Prasad, Suman, et al.
Publicado: (2017) -
39.3 CAN NEUROVIRAL INFECTIONS WITH HERPES SIMPLEX VIRUS, TYPE 1 (HSV-1) CONTRIBUTE TO RDOC?
por: Nimgaonkar, Vishwajit, et al.
Publicado: (2018)